Thought Leadership & Innovation Foundation Appoints Dr. Neena Haider
News related to:Thought Leadership & Innovation Foundation · 1 min read
MCLEAN, Va., Oct. 20, 2026 /CourierPR/ -- Thought Leadership & Innovation Foundation (TLI) has appointed Neena Haider, PhD, to its Board of Directors, effective Friday, October 16. This appointment comes at a pivotal time as TLI expands its initiatives in healthcare innovation, patient outcomes, and scientific collaboration.
Dr. Haider, a renowned geneticist and precision medicine innovator, brings extensive experience in genetics, gene therapy, and translational research to the TLI Board. As the founder and CEO of Shifa Precision, she is developing an AI-driven approach to precision medicine, focusing on predictive, preventative, and proactive care. Her work integrates complex biological information with advanced technology to enable earlier detection and more personalized interventions.
Dr. Haider's appointment strengthens TLI's commitment to bringing together scientific leaders, innovators, healthcare organizations, and patient communities. Her expertise will help TLI further strengthen its scientific foundation and identify opportunities to accelerate promising innovations across its programs and partnerships.
A pioneering geneticist, Dr. Haider was a key contributor to the Human Genome Project and has identified more than a dozen genes associated with human disease, including conditions affecting vision, kidney function, and autism. Her research has contributed to the development of gene therapies that have advanced from laboratory discovery toward clinical application.
Dr. Haider has held leadership and scientific roles involving Harvard Medical School, the National Institutes of Health, the U.S. Congress, the National Science Foundation, and NASA. Her research has been widely published and cited, and she has been an important part of TLI's work, previously participating as a scientific expert in TLI's Autism Knowledge Gateway initiative.
Dr. Haider's appointment comes at an important time for TLI as the organization expands its portfolio of initiatives focused on healthcare innovation, patient outcomes, scientific collaboration, and the translation of evidence into action. Her expertise will be invaluable as TLI continues to build bridges between research, technology, healthcare, and the communities it serves.